Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction.
The Cardiac STATus CK-MB/Myoglobin device is highly sensitive and has a high negative predictive value within 3 hours of patient presentation. The device may play a role in the re-triage of patients from the CCU to less intensive settings, resulting in a net cost savings.